tosyllysine chloromethyl ketone has been researched along with cyclic gmp in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Black, PH; Chou, IN; Robin, R | 1 |
| Donnelly, TE; Mackenzie, CW; Tse, J | 1 |
| MacLean, MR; Murray, F; Pyne, NJ | 1 |
3 other study(ies) available for tosyllysine chloromethyl ketone and cyclic gmp
| Article | Year |
|---|---|
Proteolytic enzymes, cell surface changes, and viral transformation.
Topics: Binding Sites; Cell Adhesion; Cell Aggregation; Cell Division; Cell Membrane; Cell Transformation, Neoplastic; Cyclic AMP; Cyclic GMP; Enzyme Inhibitors; Glucose; Glycosaminoglycans; Lectins; Models, Biological; Peptide Hydrolases; Phenotype; Plasminogen; Protease Inhibitors; Proteins; Thrombin; Tosyllysine Chloromethyl Ketone; Tosylphenylalanyl Chloromethyl Ketone; Trypsin Inhibitors; Viruses | 1975 |
Inactivation of cyclic GMP-dependent protein kinase by N alpha-tosyl-L-lysine chloromethylketone.
Topics: Amino Acid Chloromethyl Ketones; Animals; Cattle; Cyclic AMP; Cyclic GMP; Kinetics; Lung; Myocardium; Protein Kinase Inhibitors; Rats; Tosyllysine Chloromethyl Ketone | 1981 |
Increased expression of the cGMP-inhibited cAMP-specific (PDE3) and cGMP binding cGMP-specific (PDE5) phosphodiesterases in models of pulmonary hypertension.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 3',5'-Cyclic-GMP Phosphodiesterases; Animals; Cell Line; Cyclic AMP; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 3; Cyclic Nucleotide Phosphodiesterases, Type 5; Humans; Hypertension, Pulmonary; Male; Myocytes, Smooth Muscle; Pulmonary Artery; Rats; Rats, Wistar; Tosyllysine Chloromethyl Ketone | 2002 |